Lingying Wu
Impact in
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 42
- PARP inhibition in cancer therapy 18
- Cancer Immunotherapy and Biomarkers 7
-
- Endometrial and Cervical Cancer Treatments 37
- Co-authors
- Ning Li (30 shared papers)Jusheng An (27 shared papers)Jia Zeng (13 shared papers)Leilei Liang (10 shared papers)Xiaoguang Li (23 shared papers)Guangwen Yuan (24 shared papers)Jian Li (4 shared papers)Bin Li (12 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Gynecologic Oncology (10 papers)International Journal of Gynecological Cancer (7 papers)Frontiers in Oncology (6 papers)Annals of Oncology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lingying Wu
199 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Obstetrics and Gynecology 366
- Reproductive Medicine 336
- Cancer Research 251
- Oncology 395
- Molecular Biology 436
Countries citing papers authored by Lingying Wu
This map shows the geographic impact of Lingying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingying Wu more than expected).
Fields of papers citing papers by Lingying Wu
This network shows the impact of papers produced by Lingying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingying Wu. The network helps show where Lingying Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingying Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 85 | |
| 2 | 2022 | 76 | |
| 3 | 2007 | 66 | |
| 4 | 2017 | 57 | |
| 5 | 2022 | 53 | |
| 6 | 2016 | 42 | |
| 7 | 2014 | 38 | |
| 8 | 2015 | 38 | |
| 9 | 2012 | 31 | |
| 10 | 2022 | 29 | |
| 11 | A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. | 2007 | 29 |
| 12 | 2020 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2012 | 25 | |
| 16 | 2009 | 25 | |
| 17 | 2017 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2014 | 23 | |
| 20 | 2024 | 23 |
About Lingying Wu
Lingying Wu is a scholar working on Oncology, Obstetrics and Gynecology, Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 207 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (37 papers), PARP inhibition in cancer therapy (18 papers), Pelvic floor disorders treatments (9 papers), Cervical Cancer and HPV Research (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Obstetrics and Gynecology (366 citations), Reproductive Medicine (336 citations), Cancer Research (251 citations), Oncology (395 citations) and Molecular Biology (436 citations). Lingying Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ning Li, Jusheng An, Jia Zeng, Leilei Liang, Xiaoguang Li, Guangwen Yuan, Jian Li, Bin Li, Hong‐Tu Zhang and Tiantian Wang. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, International Journal of Gynecological Cancer, Frontiers in Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.